Achim Sauer
Impact in
-
- Diabetes Treatment and Management
- Diabetes Management and Research
-
- Immune Response and Inflammation
- Immune Cell Function and Interaction
Papers in
- Oncology 9
- Drug Transport and Resistance Mechanisms 6
- Co-authors
- Matthias Eckhardt (3 shared papers)Frank Himmelsbach (3 shared papers)Michael Mark (2 shared papers)Peter Eickelmann (2 shared papers)Thomas Klein (2 shared papers)Leo Thomas (2 shared papers)Rolf Grempler (2 shared papers)Thomas Härtung (7 shared papers)
- Journals
- Pharmaceutics (3 papers)Molecular Pharmaceutics (3 papers)Bioorganic & Medicinal Chemistry Letters (3 papers)Diabetes Obesity and Metabolism (2 papers)Drug Discovery Today (2 papers)
- Partner nations
- GermanyUnited StatesRussia
In The Last Decade
Achim Sauer
30 papers receiving 1.1k citations
Achim Sauer's Hit Papers
Peers
Comparison fields: 5 of 102
- Endocrinology, Diabetes and Metabolism 470
- Immunology 188
- Oncology 142
- Pharmacology 88
- Surgery 220
Countries citing papers authored by Achim Sauer
This map shows the geographic impact of Achim Sauer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Achim Sauer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Achim Sauer more than expected).
Fields of papers citing papers by Achim Sauer
This network shows the impact of papers produced by Achim Sauer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Achim Sauer. The network helps show where Achim Sauer may publish in the future.
Co-authors
The 25 scholars most cited alongside Achim Sauer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Empagliflozin, a novel selective sodium glucose cotransporter‐2 (SGLT‐2) inhibitor: characterisation and comparison with other SGLT‐2 inhibitors Hit paper breakdown → | 2011 | 502 |
| 2 | 1995 | 226 | |
| 3 | 2017 | 45 | |
| 4 | 2011 | 43 | |
| 5 | 1996 | 41 | |
| 6 | 1953 | 34 | |
| 7 | 1996 | 23 | |
| 8 | 2021 | 23 | |
| 9 | 2021 | 22 | |
| 10 | 2021 | 20 | |
| 11 | 1997 | 18 | |
| 12 | 2002 | 16 | |
| 13 | 2018 | 15 | |
| 14 | Testing of immunomodulatory properties in vitro. | 1996 | 15 |
| 15 | 2014 | 13 | |
| 16 | 2011 | 13 | |
| 17 | 2014 | 12 | |
| 18 | 2019 | 12 | |
| 19 | 2020 | 8 | |
| 20 | 2022 | 8 |
About Achim Sauer
Achim Sauer is a scholar working on Oncology, Molecular Biology, Pharmacology, Immunology and Cellular and Molecular Neuroscience, having authored 31 papers that have together received 1.2k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (6 papers), Immune Response and Inflammation (6 papers), Liver physiology and pathology (3 papers), Cholinesterase and Neurodegenerative Diseases (3 papers), Diabetes Treatment and Management (3 papers), Neuroscience and Neuropharmacology Research (3 papers), Cannabis and Cannabinoid Research (3 papers) and Computational Drug Discovery Methods (3 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (470 citations), Immunology (188 citations), Oncology (142 citations), Pharmacology (88 citations) and Surgery (220 citations). Achim Sauer has collaborated with scholars based in Germany, United States and Russia. Frequent co-authors include Matthias Eckhardt, Frank Himmelsbach, Michael Mark, Peter Eickelmann, Thomas Klein, Leo Thomas, Rolf Grempler, Thomas Härtung, Albrecht Wendel and Dale E. Sharp. Their work appears in journals such as Pharmaceutics, Molecular Pharmaceutics, Bioorganic & Medicinal Chemistry Letters, Diabetes Obesity and Metabolism and Drug Discovery Today.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.